文献速递围术期管理与 ERAS胃肠外科肝胆胰外科

医院再入院减少计划与手术再入院的关联

Association of the Hospital Readmissions Reduction Program With Surgical Readmissions.
PubMed 文献 · JAMA Surg · 2018-01-01

IMPORTANCE: Readmissions after surgery lead to poor patient outcomes and increased costs. The Hospital Readmissions Reduction Program (HRRP) penalizes hospitals with excess readmissions after specified medical and surgical discharges.…

要点

  • HRRP实施后靶向关节手术再入院率下降加速,非靶向手术无溢出效应。
  • 观察性住院使用略有增加,占再入院率下降的11%。
  • 政策对手术与非手术出院的影响差异需进一步研究以推广。

核心结论

  • HRRP有效降低了靶向手术的再入院率。
  • 常见非靶向手术未观察到相关的溢出效应。

研究设计与样本

  • 基于20% Medicare样本的回顾性队列研究,纳入2006年1月1日至2014年11月30日接受5种重大手术的患者。

主要发现

  • 所有手术的再入院率在研究期间均显著下降。
  • 靶向手术再入院率在绩效期下降斜率−0.060(95%CI −0.079至−0.041),快于政策前期的−0.012(95%CI −0.027至0.034)(P<.002)。
  • 非靶向手术再入院率在政策前期下降斜率−0.200(95%CI −0.240至−0.160),绩效期趋于稳定斜率0.008(95%CI −0.049至0.066)(P<.001)。
  • 观察性住院使用略有增加,占再入院率下降的11%。

临床怎么用

  • HRRP可有效降低靶向手术(如关节置换)的再入院率,临床可关注政策导向的出院管理。
  • 对于非靶向手术(如结肠切除、肺切除),未见政策溢出效应,需自行优化围术期管理以降低再入院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Readmissions after surgery lead to poor patient outcomes and increased costs. The Hospital Readmissions Reduction Program (HRRP) penalizes hospitals with excess readmissions after specified medical and surgical discharges. OBJECTIVE: To evaluate the association of the HRRP with readmissions after major joint surgery (targeted) and procedures with historically high rates not under its purview (nontargeted). DESIGN, SETTING, AND PARTICIPANTS: In this population-based analysis using a 20% Medicare sample, a retrospective cohort study was performed of patients undergoing one of 5 major surgical procedures between January 1, 2006, and November 30, 2014. The study included 507 663 patients with targeted (total knee arthroplasty and total hip arthroplasty) and 164 472 patients with nontargeted (abdominal aortic aneurysm repair, colectomy, and lung resection) procedures performed at 2773 hospitals. EXPOSURE: Implementation of the HRRP policy. MAIN OUTCOMES AND MEASURES: Hospital-level 30-day risk-adjusted rates of readmission and observation stays were calculated using multivariable logistic regression models. Changes in these rates were analyzed for 3 distinct periods (prepolicy [January 1, 2006, to June 30, 2010], performance [July 1, 2010, to June 30, 2013], and penalty [July 1, 2013, to November 30, 2014]) corresponding to the HRRP implementation timeline for major joint surgery using interrupted time series. RESULTS: Among 672 135 Medicare beneficiaries 66 years or older treated at 2773 hospitals, readmissions for all procedures decreased significantly over the study period. Readmission rates after targeted procedures decreased faster during the performance period (slope, −0.060; 95% CI, −0.079 to −0.041) compared with the prepolicy period (slope, −0.012; 95% CI, −0.027 to 0.034) (P < .002). For the nontargeted procedures, readmission rates were decreasing during the prepolicy period (slope, −0.200; 95% CI, −0.240 to −0.160) but stabilized during the performance period (slope, 0.008; 95% CI, −0.049 to 0.066 (P < .001). The use of observation stays increased slightly, accounting for 11% of the decrease in readmissions. CONCLUSIONS AND RELEVANCE: The HRRP effectively decreased readmissions for targeted procedures. There were no associated spillover effects for common nontargeted procedures. A better understanding of differences in the association of the policy with medical and surgical discharges will be necessary to further enhance its generalizability. QUESTION: What is the association of the Hospital Readmissions Reduction Program with readmissions after surgical procedures targeted by the policy and other major procedures with historically high readmission rates not under its purview? FINDINGS: In this cohort study of 672 135 Medicare beneficiaries treated at 2773 hospitals, we found that readmissions decreased significantly for all procedures during the study period. Corresponding with the performance period of the policy, readmissions after targeted procedures decreased significantly faster compared with 2 earlier periods, while readmission rates for nontargeted procedures stabilized. MEANING: The Hospital Readmissions Reduction Program may decrease readmissions for targeted procedures; however, there were no associated spillover effects for common nontargeted procedures. This cohort study evaluates the association of the Hospital Readmissions Reduction Program with readmissions after major joint surgery (targeted) and procedures with historically high rates not under its purview (nontargeted).

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Borza T, Oreline MK, Skolarus TA, et al. Association of the Hospital Readmissions Reduction Program With Surgical Readmissions. JAMA Surg. 2018. PMID: 29167870. doi:10.1001/jamasurg.2017.4585

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。